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Abstract
In the last 10 years, research on the human microbiome has grown exponentially due to
the increasing understanding of its effects on human health. The gut-brain axis has become one
area of focus, linking gut health and mental disorders. This review of the literature will examine
the connection between depression and gut health, primarily mediated by the gut microflora. Due
to the complex nature of studying the gut-brain axis and the heterogeneity of depression, recent
studies have faced some difficulty in finding significant results based on isolated nutrients,
foods, supplements, or probiotics. This proposal seeks to build on prior research to produce an
inclusive whole food-based nutrition intervention that potentially will have a more significant
impact on depressive disorders. This research will be combining well studied probiotics with a
beneficial dietary pattern in the hopes of creating a protocol that yields a more pronounced
reduction on depressive symptoms, which could be used in a clinical trial or as an adjuvant
treatment.
Keywords: Gut-Brain Axis, Depression, Mental Health, Gut Microbiome, Probiotics,
Prebiotics, Psychobiotics, Mediterranean Diet, Dietary Patterns, Nutrition Intervention
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Introduction
Depression Significance and Diagnostic Criteria
Depression is one of the most common mental disorders globally and a leading cause of
disability affecting more than 300 million people worldwide (Kessler & Bromet, 2013; World
Health Organization, 2018). Depression greatly reduces quality of life and can have major
personal, professional, and social consequences. It also has the capability to bring on suicidal
thoughts and potentially lead to death (Popa & Ladea, 2012). According to the Diagnostic and
Statistical Manual of Mental Disorders (5th ed.), the myriad of depressive disorders share
common diagnostic criteria including: “the presence of sad, empty, or irritable mood,
accompanied by somatic and cognitive changes that significantly affect the individual’s capacity
to function” (American Psychiatric Association, 2013). The different types of depressive
disorders primarily differ because of timing, duration, or presumed etiology (American
Psychiatric Association, 2013). It is understood that depression can stem from biological, social,
and environmental factors. The present research seeks to address possible biological and
environmental origins of depression.
Depression as an Inflammatory Disease
Current pharmacological treatments for depression involve the use of medications that
primarily function to adjust neurotransmitter activity, but these treatments can cause severe side
effects and withdrawal symptoms (National Institute of Mental Health, 2018; Wallace & Milev,
2017). A recent study examining the efficacy on antidepressants found them to be much less
clinically significant than previously thought (Moncrieff & Kirsch, 2005). The common notion
that depression stems solely from neurochemical imbalances has more recently been
reconsidered and depression is now hypothesized to be an inflammatory disease (Berk et al.,
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2013). Common biomarkers of depression include elevations of pro-inflammatory cytokines
including interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor - alpha (TNF-a), and
c-reactive protein (CRP) (Dowlati et al., 2010; Gururajan, Clarke, Dinan, & Cryan, 2016). It’s
also common to see evidence of stress-related physiology, such as elevated cortisol levels
(Connor & Leonard, 1998). Brain-related biomarkers of depression include lowered levels of
dopamine, serotonin Gamma-Aminobutyric Acid (GABA), and various neurotrophic factors,
especially brain-derived neurotrophic factor (BDNF) (Strawbridge, Young, & Cleare, 2017;
Gururajan et al., 2016). All these biomarkers suggest depression to be highly correlated to
inflammation, stress, immune dysfunction, and a hyperactive hypothalamus-pituitary-adrenal
(HPA) axis (Sandhu et al., 2017).
Study Aims
Berk et al. (2013) have examined the many possible sources of inflammation that may be
influencing depression. Sources of inflammation can stem from biological, social, and
environmental factors which helps explain the heterogeneity of depression. Research has shown
a strong correlation between depression and gastrointestinal dysfunction, shown in the
comorbidity of depression with many gastrointestinal disorders and related inflammatory
responses (Mangiola et al., 2016). This has led to an increased interest in studies surrounding
nutritional psychiatry, neurogastroenterology, and the gut-brain-axis (Logan & Katzman, 2005).
This paper will be examining the role of dietary patterns and gut microflora as mediators of
depression to culminate a nutrition intervention that may potentially prevent or treat depression.
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Gut-Brain Axis
The Gut-Brain Axis as a Mediator of Depression
In the last decade, a growing field of research has emerged looking into the bidirectional
connection between the central nervous system (CNS) and the gastrointestinal (GI) tract, which
is now known as the gut-brain axis. The cross talk between the GI tract and the CNS is mediated
through the autonomic and enteric nervous systems, immune system, and endocrine system
(Sandhu et al., 2017). The human GI tract is also home to over 100 trillion bacteria which make
up the gut microbiome. This microbiome is a very influential part of the gut-brain axis and has a
significant impact on human health by maintaining the intestinal barrier, supporting immune
function, metabolizing nutrients, producing short chain fatty acids (SCFAs), and producing
neurochemicals, such as 90% of the bodies serotonin (Mangiola et al., 2016; Sandhu et al.,
2017). The importance of nutrition and maintaining a healthy gut microbiome has been well
established, but the role these play in psychiatric disorders is emerging in research with
promising findings. The gut microbiome may modulate cognitive functioning and behavior
through possible mechanisms involving the immune system, HPA axis, inflammation, and the
production of neurochemicals and neurohormones (Sandhu et al., 2017). Maintenance of a
healthy gut microbiome has the potential to modulate levels of anti-inflammatory cytokines,
reduce oxidative stress, and increase BDNF, GABA, and serotonin, all of which have negative
correlations with depression (Logan & Katzman, 2005).
The Gut-Microbiome - An Ecosystem Within Us
The gut microflora is unique to every individual and is influenced by several factors
including genetics, lifestyle, birthing method, antibiotic history, and dietary patterns (Sandhu et
al., 2017). It is well established which bacteria are beneficial versus harmful, and the balance
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between positive and negative species is essential to host health. An unbalanced microflora is
known as dysbiosis and is directly correlated to a plethora of disorders and diseases, one of
which being depression. Although everyone’s microbiome is distinct, similar populations share
certain species, quantities, and diversity (Sandhu et al., 2017). Healthy individuals are primarily
populated by the phyla Firmicutes and Bacteroidetes, which contain many beneficial species
including the well-known Bifidobacterium and Lactobacillus (Johnson et al., 2012). Individuals
with depressive disorders have shown to have an abundance of Enterobacteriaceae (phyla
containing mostly pathogenic species), and lower levels of Bifidobacterium and Lactobacillus
(gram positive beneficial bacteria) when compared to healthy subjects (Aizawa et al., 2016;
Jiang et al., 2015; Sandhu et al., 2017). In a study by Zheng et al. (2016), fecal microflora from
patients with major depressive disorder (MDD) were transplanted into germ free mice. This
induced depressive-like behaviors and caused metabolic dysfunction when compared to mice
who received fecal microflora transplants from healthy subjects (Zheng et al., 2016). There have
been numerous other demonstrations that depression may stem from negative alterations in gut
microflora.
From Probiotics to Psychobiotics
Probiotics are defined as “live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host” (Hill et al., 2014, p. 506). Probiotics have been
prescribed by doctors for many gut-related disorders, but as the understanding of the gut-brain
axis has evolved a new era of probiotics has been termed “psychobiotics” for their influence on
the CNS, cognition, and behavior (Dinan, Stanton, & Cryan, 2013). In a systematic review on the
effects of probiotics on the CNS, it was found that probiotics can improve CNS functioning
possibly through increasing BDNF levels, enhancing serum tryptophan, and decreasing pro-
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inflammatory cytokines (Wang, Lee, Braun, Enck, 2016). In a study on Ulcerative Colitis,
probiotics were found to diminish inflammation by decreasing IL-6 and TNF-a concentrations,
both of which are inflammatory biomarkers of depression (Hegazy & El-Bedewy, 2010).
Akkasheh et al. (2015), found that probiotic treatment to patients with MDD significantly
reduced signs of oxidative stress and CRP levels, other inflammatory biomarkers of depression.
A growing body of research is examining the efficacy of specific probiotic strains for the
treatment of depression, those with promising results are summarized and presented in Table 1.
These studies focus on increasing the quantity and diversity of beneficial gut bacteria, primarily
using Bifidobacteria and Lactobacillus supplementation, to bring dysbiotic microflora back to a
healthy status.
Table 1. Probiotics for Depression
This table provides a list of probiotic strains with corresponding evidence in preclinical and
clinical studies for the treatment of depressive disorders or associated risk factors. Clinical
diagnosis, method of probiotic treatment, and depression scales may differ between studies due
to the heterogeneity of depression.
Probiotic Strain
B. bifidum

B. infantis

Authors

Study Design

Overview

Akkasheh et al.
(2016)

Randomized
double-blind
placebo
controlled

Probiotic formula (L. acidophilus, L. casei, B.
bifidum) administered to 20 patients with MDD
over 8 weeks significantly decreased scores on
Beck Depression Inventory

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention
assessment

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a
precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

Desbonnet et al. Preclinical
(2010)
animal study

B. Infantis proved to be nearly as effective as
citalopram (a common antidepressant) in
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normalizing forced swim test behaviors in a rat
maternal separation model, which is a reliable
marker of antidepressant activity.
B. lactis

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention
assessment

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a
precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

B. longum

Messaoudi et
al. (2011)

Randomized
double- blind
placebo
controlled

The probiotic formula of L. helveticus and B.
longum reduced anxiety and in preclinical rats
and had beneficial psychological effects
(including depression reduction) in 26 human
volunteers.

Pinto-Sanchez
et al. (2017)

Randomized
double-blind
placebo
controlled pilot
study

Pilot study found that B. longum reduces
depression and increases quality of life in 22
patients with IBS compared to controls.

Akkasheh et al.
(2016)

Randomized
double-blind
placebo
controlled

Probiotic formula (L. acidophilus, L. casei, B.
bifidum) administered to 20 patients with MDD
over 8 weeks significantly decreased scores on
Beck Depression Inventory

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention
assessment

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a
precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a

L. acidophilus

L. brevis
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assessment

precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

Akkasheh et al.
(2016)

Randomized
double-blind
placebo
controlled

Probiotic formula (L. acidophilus, L. casei, B.
bifidum) administered to 20 patients with MDD
over 8 weeks significantly decreased scores on
Beck Depression Inventory

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention
assessment

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a
precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

L. helveticus

Messaoudi et
al. (2011)

Randomized
double- blind
placebo
controlled

The probiotic formula of L. helveticus and B.
longum reduced anxiety and in preclinical rats
and had beneficial psychological effects
(including depression reduction) in 26 human
volunteers.

L. plantarum

Liu et al.
(2016)

Preclinical
animal study

L. plantarum effectively decreased serum IL-6
levels and improved depressive behaviors in
mice with early life stress

L. reuteri

Ma, Forsythe,
& Bienenstock
(2004)

Preclinical study

L. Reuteri directly inhibited IL-8 and TNF-alpha,
promoting an anti-inflammatory effect on human
epithelial cells.

L. rhamnosus

Slykerman et
al. (2017)

Randomized
double-blind
placebo
controlled

Study showed a significant reduction of
depressive and anxiety postpartum symptoms in
212 women compared to placebo group.

L. salivarius

Steenbergen et
al. (2015)

Triple-blind,
placebo
controlled,
randomized, pre
and post
intervention
assessment

20 healthy participants were administered a
probiotic formulation of B. Bifidum, B. lactis, L.
acidophilus, L. brevis, L, casei, L. salvarius, and
L. lactis for a 4-week period. Leiden Index of
Depression Sensitivity Scale was used to
measure cognitive reactivity to sad mood (a
precursor for depression) and the probiotic
formulation showed significant reductions on
scale.

L. casei
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Research Significance and Recommendations
Based on the results of these articles, it’s reasonable to conjecture that a combination of
these beneficial probiotic species may be a promising option for the prevention and treatment of
depression. An important thing to mention is that few of these studies have large sample sizes,
control for diet and prebiotic consumption, use modes of transmission beside capsulized
probiotics, or analyze the stool to confirm the probiotics were able to colonize in the lower GI
tract. The efficacy of probiotics relies on their ability to survive through the stomach and adhere
permanently to the epithelium of the large intestine. Their ability to do so depends on how the
cultures were administered, the presence of prebiotics, and the quantity and quality of the
probiotic culture (Johnson et al., 2012). Although these studies have found clinically relevant and
promising results, it is possible that these findings could be improved if more measures are taken
to ensure the colonization of probiotic species in the GI tract.
The Role of Nutrition
The Importance of Diet and Prebiotics
The most effective way to rapidly improve the gut microbiome and promote the
colonization and growth of beneficial species is through diet (Singh et al., 2017). Although the
use of probiotic supplements has demonstrated potential effectiveness in promoting the integrity
of the microbiome and improving depressive symptoms, research suggests that the influence of a
healthy diet and consumption of probiotic foods and drinks may be more influential (Walker et
al, 2011). The probiotic research presented in Table 1 primarily establishes what specific species
show the most promise in influencing mood and depressive symptoms. These “psychobiotic”
species include B. bifidum, B. infantis, B. lactis, B. longum, L. acidophilus, L. brevis, L. casei, L.
helveticus, L. plantarum, L. reuteri, L. rhamnosus, and L. salivarius. These species can be found

A FUNCTIONAL APPLICATION OF THE GUT-BRAIN AXIS

11

in a variety of fermented foods and drinks including fermented dairy products, sauerkraut,
kimchi, kombucha, etc. Another main way diet supports microbiome health is from the presence
of prebiotics, specific nondigestible foodstuffs, that feed beneficial bacteria which then
outcompete harmful species (Singh et al, 2017). Prebiotics include fructooligosaccharides,
galactooligosaccharides, lactulose, cereal fibers, resistant starches, lactosucrose, soybean, and
oligosaccharides (Johnson et al., 2012). To see more significant clinical results for treating
depression the consumption of probiotics, prebiotics, and quality of diet must be established to
improve the gut microbiome and feed these psychobiotic species.
Dietary Patterns
A fundamental approach to achieving optimal function of the gut-brain axis is through
specific nutritional interventions focused on dietary patterns. While some research has focused
on the use of specific vitamins, minerals, and other supplements to promote gut and brain health,
results are mixed (Wallace & Milev, 2017). This has led many to propose that, rather than
focusing on isolated nutrients, examining diet patterns as a whole may be more impactful when
studying mental health, especially depression (Del Chierico, Vernocchi, Dallapiccola, &
Putignani, 2014). There is a growing body of research that supports the Mediterranean diet as an
effective prevention or treatment plan for depression as they are inversely related (Psaltopoulou
et al., 2013; Sanchez-Villegas et al., 2007; Sandhu et al., 2017). Correspondingly, there is a
strong correlation between the Western diet (high in refined carbohydrates, animal protein and
fat) and depression, along with the comorbidity of many other metabolic disorders (Jacka et al,
2010; Psaltopoulou et al., 2013). Studies continue to evaluate the possible antidepressant
properties of the Mediterranean dietary pattern, one of which may be the positive impact it has
on the gut microbiome (Sanchez-Villegas et al., 2007). Research has compared the influence of
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dietary patterns on gut microflora and found that Western diets limit microflora density and show
a reduction in amounts of Bifidobacteria and Lactobacillus and an increase in Enterobacteria
(Singh et al., 2017). On the other hand, the Mediterranean diet increases microflora diversity and
promotes the growth of Bifidobacteria and Lactobacillus (see figure 1.) (Singh et al., 2017).

Figure 1. Western diet vs. Mediterranean diet effects on microflora (Singh et al., 2017).

The Mediterranean Diet and the Gut Microbiome
The Mediterranean Diet: What is it?
The Mediterranean diet has come to be known as one of the healthiest and most
beneficial ways of eating. The Mediterranean diet is an eating pattern characterized by daily
intake of unrefined grains, vegetables, fruit, olive oil, and dairy, with a moderate intake of fish,
poultry, eggs, sweets, and legumes, and rarely red meat. (see figure 2).
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Figure 2. The Mediterranean Diet food pyramid (Trichopoulou, 2004).

Mediterranean Diet Carbohydrates (Prebiotics)
In a study done by Filippis et al. (2016), the microbiomes of 153 volunteers were
analyzed in relation to their adherence to a Mediterranean diet. The results of the study found
that dietary patterns closest to that of the Mediterranean diet were associated with healthier
microbiome profiles compared to those consuming a Western diet (Filippis et al., 2016). A large
portion of the Mediterranean diet is composed of fruits, vegetables, and foods high in fiber,
which provide the variety of prebiotics that promote beneficial gut bacteria. Prebiotics, such as
fructooligosaccharides, oligosaccharides, cereal fibers, and resistant starches found in the
Mediterranean diet, are often indigestible carbohydrates that can only be broken down by
beneficial species such as Bifidobacterium and Lactobacillus. The consumption of these
prebiotics allows beneficial gut microbes to produce SCFA, such as butyrate, that directly
support digestive function and produce anti-inflammatory effects (Singh et al., 2017). Prebiotic
consumption is associated with reductions of pro-inflammatory cytokine IL-6, increases in the
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anti-inflammatory cytokine IL-10, and other positive metabolic markers while also increasing
microflora density and diversity (Martinez et al., 2013; Singh et al., 2017).
Mediterranean Diet Proteins
Aside from its high content of beneficial carbohydrates, the Mediterranean dietary pattern
also emphasizes a reduced consumption of meat and promotes the ingestion of healthy fats. Meat
intake and fat quality have also shown to influence the composition of the gut microbiome and
may add to the success of the Mediterranean diet in reducing depression. Plant protein rich diets
increase microflora diversity and can increase beneficial microbes, but diets with high
consumption of animal-based protein produce an opposite effect. Diets high in animal-based
protein increase counts of Bacteroides, Alistipes, and Bilophila, which increase protein
fermentation that lead to toxic metabolites. These metabolites are associated with the
development of cancer, irritable bowel disease, and cardiovascular disease (Singh et al. 2017;
Sandhu et al., 2017). De Filippo et al. (2010), found that an animal protein rich diet produces
fewer SCFA’s, which protect the gut membrane and reduce inflammation. Diets high in animal
protein and low in prebiotic foods promote the colonization of harmful species, which degrades
the health of the gut microflora.
Mediterranean Diet Fats
Other nutrient components of the Mediterranean diet may also serve as protective agents
against depression. The emphasis on healthy mono- and polyunsaturated fat (PUFA)
consumption in the Mediterranean diet increases omega-3 levels which may play a major role in
inflammatory responses (Simopoulos, 2002). The ratio of omega-6 to omega-3 PUFA
consumption is understood to be of importance when it comes to human health. A high ratio of
omega-6/omega-3 has been highly correlated to inflammatory diseases, especially in Western
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cultures where the average PUFA ratio is 16-1 when it is recommended to be 2-1 or 1-1
(Simopoulos, 2002). The Mediterranean diet supports a high consumption of fish and olive oil
(both high in omega-3) which has shown to decrease pro-inflammatory markers such as IL-6,
CRP, and TNF-a (Bountziouka et al., 2009). Studies have shown that a lack of dietary omega-3
is correlated with depression, and populations with a higher PUFA ratio have higher prevalence
of major depressive disorders (Bountziouka et al., 2009).
Conclusions
Summary of Research
As the understanding of the gut-brain axis evolves, research continues to find connections
between depression, gut microflora, and the Mediterranean diet. Studies continue to search for
isolated solutions from probiotics and nutritional aspects, but it is apparent the success from
recent research stems from a cumulative effect that diet has on the microflora, and that the
microflora has on the brain. As depression is now seen as an inflammatory disease, it is crucial to
pinpoint the root of this inflammation and find functional ways to reduce it. As the GI tract is the
body’s largest immune organ, the idea that gut inflammation can be the underlying cause of
some depressive disorders is not unlikely. The culmination of this research has uncovered the
mechanisms by which diet can improve gut microflora, and in turn may decrease depressive
symptoms. Figure 3 presents a simplified version of the mechanistic actions of this nutrition
intervention. Essentially, what we eat influences the composition of our gut microbiota and thus
what metabolites are produced. When eating a healthy diet rich in probiotics and prebiotics we
feed the beneficial microbes in our gut and they return the favor by producing anti-inflammatory
metabolites, energy, and beneficial neurochemicals. These metabolites then reduce systemic
inflammation by regulating the immune system and calming the HPA axis, which helps bring the
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body back into homeostasis and reduces depressive symptoms. The beneficial neurochemicals
produced by the microflora are able to pass the blood-brain barrier and regulate levels of BDNF,
GABA, dopamine, and serotonin in the brain, also thus reducing depressive symptoms.

Figure 3. Influence of proposed nutrition intervention on gut microbiome and cognitive
functioning.

Proposed Nutrition Intervention
Through this research, a nutrition intervention based on a Mediterranean dietary model
with an emphasis on the consumption of probiotic and prebiotic foods may successfully prevent/
treat depressive disorders. The outline of this intervention is presented in Figure 4.
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This nutrition intervention is not all inclusive, but a recommendation based on the present
research. This intervention is a non-harmful, holistic, accessible, and potentially effective way to
prevent or manage depressive symptoms. For depressed populations who have a history of
antibiotic use, poor dietary habits, or other inflammatory or GI problems (such as eczema or
IBS) this nutrition intervention could serve as an extremely beneficial solution. This intervention
is not meant to replace current depression treatments and individuals should always consult their
physician before making any large scale dietary changes. This recommendation is meant to be a
supplemental, holistic way to potentially address depression and more research is needed to
support its efficacy in clinical trials.
Future Perspectives
In the future, research on this topic must approach it from a more functional direction by
implementing larger scale nutrition interventions and probiotic treatments to modulate
depression. Present research focused on isolated nutrients and single probiotic strains continues
to show promise but lacks large sample sizes and high significance. No single nutrient or single
probiotic strain is going to solve the depression epidemic. Dietary habits need to be controlled,
effective methods to promote probiotic colonization need to be used, and stool samples must be
analyzed to produce more conclusive results. Diet, microflora, and mood are clearly interrelated,
and more research is necessary to reveal the mystery of this connection. As projects such as the
Human Microbiome Project (National Institute of Health) make advancements in uncovering the
complex world of our microbiomes, more studies need to solidify the best practices for ensuring
colonization of beneficial microbes in the GI tract and how nutrition affects the ecosystem in our
gut. Research on the gut microbiome and the influence of nutrition expands beyond depression to
a variety of other psychiatric disorders, as well as numerous metabolic disorders. As this field of
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research grows, it is very clear the ecosystems within our bodies may play a much larger role in
our mental health than previously understood.
Limitations
One of the main limitations of this research is the heterogeneity of depression and how
this causes many discrepancies among current research. There are a multitude of diagnoses for
depressive disorders and a similar plethora of scales to measure them. The present research only
addresses depression from an inflammatory perspective that focuses on inflammation stemming
from the gut. This does not account for possible other roots of inflammation but may serve as a
way to promote anti-inflammatory responses systemically. This nutrition intervention may not be
applicable among all people due to the personalized nature of the gut microbiome. Some
research has supported a personalized nutrition intervention based off individual microbiomes
and genetics. The present approach supports a general dietary plan that can be modified by
individuals and is based off the healthiest dietary model currently acknowledged by science.
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